Newsroom

NIAGARA FALLS, N.Y. & NEW ORLEANS--(BUSINESS WIRE)--Altera Digital Health, a global health IT leader, today announced the general availability of Sunrise™ Medical Photography powered by TRUE-See®, a suite of documentation tools within the Sunrise platform that produces color-calibrated medical photos and videos—critical for verifiably accurate assessment of wounds, dermatological issues, surgical sites and more. Leveraging TRUE-See’s proprietary technology, the solution is intended for use acro...

ARLINGTON, Mass.--(BUSINESS WIRE)--Maestra.io Ends 2025 with 5x US ARR Growth All-in-one ecommerce personalization platform grows US ARR +453% YoY...

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the U.S. Food and Drug Administration (FDA) has accepted for priority review the New Drug Application (NDA) for centanafadine, an investigational, once-daily extended release capsule and the first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit hyperactivity d...

CHICAGO--(BUSINESS WIRE)--Kira evolves to meet rising demands for speed, accuracy, and trusted GenAI in contract intelligence...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company’s website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to refle...

SAN DIEGO--(BUSINESS WIRE)--Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics discovered using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced the issuance of a composition of matter patent by the United States Patent and Trademark Office, covering its proprietary small molecule program, including the development candidate SB-0110, for Parkinson’s disease. The newly issued patent (US12508267B2) strengthens Sinopia’s intellectual...

AUSTIN, Texas--(BUSINESS WIRE)--ElephantSqlDB, Inc., a NVIDIA Inception partner that announced the general availability of its quantum-augmented database platform on August 5, 2025, today opened a pre-IPO investment round to verified accredited investors. Since the platform launch, the Company has secured $143 million in active proof-of-concept engagements and closed a $3 million institutional funding round, positioning it for a planned NASDAQ listing within 12 months. INVESTMENT HIGHLIGHTS NVI...

AUSTIN, Texas--(BUSINESS WIRE)--Brinqa closes a standout 2025, marked by 164% YoY new bookings growth and expanding adoption among some of the world’s most complex organizations....

NEW YORK--(BUSINESS WIRE)--Apex Fintech Solutions Inc. (“Apex”), an innovation launchpad for the global investing ecosystem, today announced the launch of its Apex AI Suite featuring one of the first Agentic Development Kits (ADK) in the clearing and custody industry. This revolutionary tool accelerates developer integration with the AscendOS™ clearing, custody, and trading platform through natural language commands – enabling engineers to ramp up more quickly while empowering non-technical use...

SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Aptiv announced key leadership appointments for its Electrical Distribution Systems business, which will be named Versigent after its tax-free spin....